Neutral
Metagenomi Highlights Q1 Progress on MGX-001 Gene Therapy
Metagenomi reported strong Q1 2026 financial results, with cash reserves of $140.2 million expected to fund operations through Q4 2027. The company ad...
MGX
--
--
--
--
Price Chart (30 Days)
Ad Space
Analyst Sentiment
Bullish (0)
Neutral (1)
Bearish (0)
Latest MGX News
Neutral
Research MGX on:
Ad Space